Form D · Other Health Care
BIOTHELIUM INC.
Los Angeles, CA · CIK 0001718174
Offering snapshot reported Oct 13, 2017 · SEC filing
- Reported sold
- $147 Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $147 Reported outside-investor minimum
- First sale
- Aug 10, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2017 | Initial | $147 | No comparison | 1 | SEC filing |
| Oct 13, 2017 | Initial | $100 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-296627
Source: Form D, filed Oct 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cesar Blanco | Director, Executive |
| Gary Hutchinson | Director, Executive |
| Jonathan Lasch | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1042 Downey Way, Drb 101
Los Angeles, CA, 90089
Los Angeles, CA, 90089